Hawthorn Extract

Synonyms: 山楂提取物
Hawthorn Extract 是一种具有口服活性的山楂提取物,可降低主动脉中 Bax 表达并升高 Bcl-2 表达,调控 AMPK 信号通路以诱导细胞凋亡 (apoptosis)、增强肝脏抗氧化系统并改善肝损伤、炎症及癌症症状,同时降低促炎因子的血浆水平、升高抗炎脂联素水平以缓解主动脉粥样硬化斑块病变,改善慢性心力衰竭相关症状,抑制 FMLP 诱导的中性粒细胞超氧阴离子生成、弹性蛋白酶 (Elastase) 释放、ILB4 产生及钙信号传导,减少 LPS 诱导的中性粒细胞细胞因子生成,诱导自噬 (autophagy) 并抑制肠道干细胞增殖,可用于动脉粥样硬化、肝炎、酒精性肝病、非酒精性脂肪性肝病、肝细胞癌、慢性心力衰竭及低血压的相关研究。
山楂提取物
产品编号: MS-P56157
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
3-5 天
200mg
询价
询价
500mg
询价
询价
(0.1 - 0.2mg)
询价
询价

产品描述

Hawthorn Extract 是一种具有口服活性的山楂提取物,可降低主动脉中 Bax 表达并升高 Bcl-2 表达,调控 AMPK 信号通路以诱导细胞凋亡 (apoptosis)、增强肝脏抗氧化系统并改善肝损伤、炎症及癌症症状,同时降低促炎因子的血浆水平、升高抗炎脂联素水平以缓解主动脉粥样硬化斑块病变,改善慢性心力衰竭相关症状,抑制 FMLP 诱导的中性粒细胞超氧阴离子生成、弹性蛋白酶 (Elastase) 释放、ILB4 产生及钙信号传导,减少 LPS 诱导的中性粒细胞细胞因子生成,诱导自噬 (autophagy) 并抑制肠道干细胞增殖,可用于动脉粥样硬化、肝炎、酒精性肝病、非酒精性脂肪性肝病、肝细胞癌、慢性心力衰竭及低血压的相关研究。

生物实验数据

生物活性 Hawthorn Extract is an orally active hawthorn extract that decreases Bax expression while increasing Bcl-2 expression in the aorta, modulates the AMPK signaling pathway to induce apoptosis, enhances the hepatic antioxidant system, and ameliorates liver injury, inflammation, and cancer symptoms; it also reduces plasma levels of pro-inflammatory factors and elevates the anti-inflammatory adiponectin level to alleviate atherosclerotic plaque lesions in the aorta, improves symptoms associated with chronic heart failure, inhibits FMLP-induced neutrophil superoxide anion production, elastase release, ILB4 production, and calcium signaling, reduces LPS-induced neutrophil cytokine production, induces autophagy, and suppresses intestinal stem cell proliferation, and can be used for research on atherosclerosis, hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, hepatocellular carcinoma, chronic heart failure, and hypotension.
体外研究
(In Vitro)

Hawthorn extract (0.4-1%) 可保护人肝癌 HepG2 细胞免受酒精诱导的损伤。
Hawthorn extract (0.5-8.66 μg/mL) 可降低人肝癌 HepG2 细胞的存活率;其中,C. pinnatifida 果实乙醇提取物 (0.8 mg/mL) 可通过改变 caspase-3、Bax 和 Bcl-2 的 mRNA/蛋白水平诱导细胞凋亡,C. pinnatifida 果实 80%丙酮提取物的 IC50 为 11.58 μg/mL,C. armena 茎、花及果实 80%乙醇提取物的 IC50 为 8.66 μg/mL。
Hawthorn extract 可阻断离体豚鼠心室肌细胞中的复极化钾电流,模拟 III 类抗心律失常药物的活性。
Hawthorn extract (0.75-250 μg/mL; 5 min preincubation, 60 min incubation with FMLP) 可强效抑制 FMLP 诱导的人外周血中性粒细胞中超氧阴离子的生成,其 IC50 为 43.6 μg/mL。
Hawthorn extract (0.75-250 μg/mL; 5 min preincubation, incubation with FMLP) 可强效抑制 FMLP (MS-G50736) 诱导的人外周血中性粒细胞弹性蛋白酶释放,其 IC50 为 21.9 μg/mL,且无直接抑制弹性蛋白酶活性的作用。
Hawthorn extract (0.75-250 μg/mL; 30 min preincubation) 可强效抑制 FMLP 诱导的人外周血中性粒细胞趋化迁移,其 IC50 为 31.6 μg/mL。
Hawthorn extract (125 μg/mL; 60 min preincubation, 5 min cytochalasin B treatment, 5 min FMLP incubation) 可显著抑制 FMLP 诱导的人外周血中性粒细胞中 LTB4 的生成,且不影响基础状态下的 LTB4 释放。
Hawthorn extract (125 μg/mL; 1 h preincubation, 8 h incubation with LPS) 可显著抑制 LPS (MS-X54539) 诱导人外周血中性粒细胞产生 TNF-α 和 IL-8,且不影响细胞因子的基线水平。
Hawthorn extract (0.75-125 μg/mL; 10 min preincubation, FMLP stimulation) 可强效抑制 FMLP 诱导的人外周血中性粒细胞内[Ca2+]i 升高,其 IC50 为 17.4 μg/mL;在 20 μg/mL 和 125 μg/mL 浓度下,还可阻断细胞外钙内流、细胞内钙释放以及电容性钙内流。

Cell Migration Assay

Cell Line: FMLP-induced human peripheral blood neutrophils
Concentration: 0.75-250 μg/mL
Incubation Time: 30 min
Result: Inhibited FMLP-induced chemotactic migration.
体内研究
(In Vivo)

Hawthorn extract (50 mg/kg;口服;每日;16 周) 在 ApoE-/-小鼠中展现出抗动脉粥样硬化功效,可将主动脉斑块面积降至 20.3%,并通过抑制炎症和凋亡信号通路调控血脂谱、炎症因子及凋亡相关标志物。
Hawthorn extract (1-3 mg/mL;口服;持续膳食补充) 可将黑腹果蝇的寿命延长至多 13.7% (3 mg/mL 组雄性果蝇的平均寿命),同时提升其应激耐受性、增强抗氧化活性、维持肠道稳态、抑制 PI3K-Akt 通路活性并激活自噬。

Animal Model: ApoE-/- (8-week-old male, 19-21 g, fed high-fat diet for 16 weeks)
Dosage: 50 mg/kg
Administration: p.o.; daily; 16 weeks
Result: Significantly decreased plasma levels of total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C), and increased plasma high-density lipoprotein cholesterol (HDL-C).
Reduced the percentage of aortic plaque area from 61.2% to 20.3%.
Decreased plasma levels of monocyte chemoattractant protein-1 (MCP-1), interleukin-1β (IL-1β), and hypersensitive C-reactive protein (hs-CRP), and increased plasma adiponectin (APN) level.
Reduced aortic protein and mRNA expression of Bax, and increased aortic protein and mRNA expression of Bcl-2.
Animal Model: w1118 strain; Esg-Gal4 USA-GFP transgenic strain (male and female, 2 days old at study start)
Dosage: 1 mg/mL; 3 mg/mL
Administration: p.o.; continuous dietary supplementation
Result: Extended both the mean and maximum lifespan of fruit flies.
Reduced the reproductive capacity of fruit flies.
Enhanced the climbing ability of fruit flies.
Extended the mean survival time of fruit flies under conditions of paraquat exposure, H2O2-induced oxidative stress, heat shock, and starvation stress.
Reduced the recovery time of fruit flies following cold shock.
Increased the activity levels of SOD1, SOD2, and CAT within fruit flies, while simultaneously reducing MDA content.
Reduced the proportion of "Smurf" fruit flies (those exhibiting intestinal barrier dysfunction).
Reduced the colony-forming unit (CFU) counts of LMRS, ACE, and NR bacterial colonies within the fruit fly gut.
Reduced the proliferation rate of intestinal stem cells (ISCs) in fruit flies.
Increased the level of lysosomal staining in fruit flies.
Increased the mRNA expression levels of Atg1, Atg5, Atg8a, and Atg8b within fruit flies.
Increased the mRNA expression levels of SOD1, SOD2, and CAT within fruit flies; decreased the mRNA expression levels of PI3K and Akt-1; and increased the mRNA expression level of FOXO.
性状 固体
颜色 Yellow to brown

化学信息

别名 山楂提取物

储存&溶解度

储存方式

Store at room temperature, keep dry and cool

In solvent -80°C 1 year
-20°C 6 months
运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础